Bin‐Zhi Qian
Impact in
- Immunology top 0.2%
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Oncology top 0.2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
Papers in
-
- Single-cell and spatial transcriptomics 4
- Wnt/β-catenin signaling in development and cancer 4
- Epigenetics and DNA Methylation 4
- Oncology 22
- Cancer Cells and Metastasis 8
- Cancer Immunotherapy and Biomarkers 6
- Chemokine receptors and signaling 5
- Co-authors
- Jeffrey W. Pollard (18 shared papers)Takanori Kitamura (6 shared papers)Jiufeng Li (10 shared papers)Hui Zhang (6 shared papers)Jinghang Zhang (2 shared papers)Linda A. Snyder (2 shared papers)Liam Campion (1 shared paper)Ruoyu Ma (6 shared papers)
- Journals
- Cancer Research (8 papers)The Journal of Experimental Medicine (3 papers)Oncotarget (2 papers)The Journal of Cell Biology (2 papers)Advanced Materials (1 paper)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Bin‐Zhi Qian
41 papers receiving 11.5k citations
Bin‐Zhi Qian's Hit Papers
Peers
Comparison fields: 5 of 142
- Immunology 6.2k
- Oncology 4.9k
- Cancer Research 1.7k
- Molecular Biology 3.7k
- Biotechnology 379
Countries citing papers authored by Bin‐Zhi Qian
This map shows the geographic impact of Bin‐Zhi Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin‐Zhi Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin‐Zhi Qian more than expected).
Fields of papers citing papers by Bin‐Zhi Qian
This network shows the impact of papers produced by Bin‐Zhi Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin‐Zhi Qian. The network helps show where Bin‐Zhi Qian may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin‐Zhi Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage Diversity Enhances Tumor Progression and Metastasis Hit paper breakdown → | 2010 | 4170 |
| 2 | CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis Hit paper breakdown → | 2011 | 2311 |
| 3 | Immune cell promotion of metastasis Hit paper breakdown → | 2015 | 929 |
| 4 | A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth Hit paper breakdown → | 2009 | 563 |
| 5 | CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages Hit paper breakdown → | 2015 | 533 |
| 6 | Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage–Derived VEGFA Hit paper breakdown → | 2015 | 484 |
| 7 | Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy Hit paper breakdown → | 2015 | 416 |
| 8 | Macrophage diversity in cancer revisited in the era of single-cell omics Hit paper breakdown → | 2022 | 392 |
| 9 | 2017 | 220 | |
| 10 | Fluorescence-amplified nanocrystals in the second near-infrared window for in vivo real-time dynamic multiplexed imaging Hit paper breakdown → | 2023 | 196 |
| 11 | 2015 | 162 | |
| 12 | 2014 | 156 | |
| 13 | 2019 | 149 | |
| 14 | 2009 | 128 | |
| 15 | 2020 | 122 | |
| 16 | 2012 | 100 | |
| 17 | 2017 | 89 | |
| 18 | 2019 | 58 | |
| 19 | 2021 | 56 | |
| 20 | 2000 | 52 |
About Bin‐Zhi Qian
Bin‐Zhi Qian is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Cell Biology, having authored 45 papers that have together received 11.6k indexed citations. Recurring topics across this work include Immune cells in cancer (19 papers), Cancer Cells and Metastasis (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Chemokine receptors and signaling (5 papers), Single-cell and spatial transcriptomics (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). The work is most often cited by research in Immunology (6.2k citations), Oncology (4.9k citations), Cancer Research (1.7k citations), Molecular Biology (3.7k citations) and Biotechnology (379 citations). Bin‐Zhi Qian has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Jeffrey W. Pollard, Takanori Kitamura, Jiufeng Li, Hui Zhang, Jinghang Zhang, Linda A. Snyder, Liam Campion, Ruoyu Ma, Annabel Black and Richard A. Lang. Their work appears in journals such as Cancer Research, The Journal of Experimental Medicine, Oncotarget, The Journal of Cell Biology and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.